The Impact Of The Irinotecan (Iri) Schedule On Quality Of Life In Combination With Capecitabine (Cap) In First-Line Treatment Of Metastatic Colorectal Cancer (Mcc): A Randomized Phase Ii Trial Of The Swiss Group For Clinical Cancer Research.